Has Matthew Eckermann, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,838 in general payments to Matthew Eckermann, MD across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Eckermann, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Eckermann, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Eckermann, MD

Anesthesiology · Parker, CONPI 1679543474

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,967 of the $2,838 with a category attached, or 69.3%. 28 manufacturers reported payments, led by Stryker at 33.8% of the total. Reporting peaked in 2019 at $1,313 and has fallen 77.1% since, to $301 in 2025. Among anesthesiology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,838in general payments, 2019–2025

Across 72 payments — averaging $39.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$961
Si-bone, Inc.$281
Medtronic$163
Boston Scientific$161
Arthrex$157
Avanos Medical$155
plus $960 from 22 others

What the payments were for

Travel & lodging$87131%
Food & beverage$1,96769%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	5	$961
Si-bone, Inc.	2	$281
Medtronic(2 entities)	3	$163
Boston Scientific	4	$161
Arthrex	4	$157
Avanos Medical	3	$155
Biohaven Pharmaceuticals, Inc.	4	$95
Lilly USA, LLC	6	$92
Scilex Pharmaceuticals Inc.	5	$83
AbbVie	4	$81
Amgen(2 entities)	3	$63
Biodelivery Sciences International, Inc.	4	$62
Pacira Pharmaceuticals Incorporated	2	$59
Vertos Medical, Inc.	2	$56
Collegium Pharmaceutical, Inc.	4	$55
Nalu Medical, Inc.	2	$41
Lundbeck LLC	2	$37
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$31
IBSA Pharma Inc.	2	$30
Gemini Mountain Medical, LLC	1	$28
Nevro Corp.	1	$24
Abbott	1	$23
Teva Pharmaceuticals USA, Inc.	1	$20
Bioventus LLC	1	$19
KCI USA, Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$17
Relievant Medsystems, Inc.	1	$15
Pfizer	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IVS - VERTEBRAL AUGMENTATION PRODUCTS$863
iFuse Implant$146
ON-Q* PUMP AND ACCESSORIES$124
INTELLIS$122

How this compares

$2,838 in reported general payments places this provider in the 95th percentile of 921 anesthesiology providers in Colorado.

See all anesthesiology providers in Colorado →

Medicare billing

Part B allowed, 2024

$52,471

Medicare patients

129

Services billed

397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	21	$6,061
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	61	$1,860
Morphine Sulfate ErMorphine Sulfate	80	$1,833
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	42	$1,372
Oxycodone Hcl	49	$805
Morphine Sulfate	14	$530
Tramadol Hcl	27	$151
Pregabalin	14	$134
Gabapentin	13	$108

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Parker

Jeffrey GonzalesAurora$774K
Darin RentzLakewood$311K
John StorheimGrand Junction$145K
Dennis KotelkoDenver$116K
Shawn MarshLone Tree$89K
Giancarlo ChecaEnglewood$89K
Shawn SnowColorado Springs$75K
Andrew MortensonColorado Springs$46K
Robert Carter JonesGreenwood Village$37K
Adam WeingartEnglewood$26K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →